Cargando…

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Sigrun Alba Johannesdottir, Johansen, Martin Berg, Olsen, Morten, Xu, Xiao, Parker, Joseph M, Molfino, Nestor A, Lash, Timothy L, Sørensen, Henrik Toft, Christiansen, Christian Fynbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275660/
https://www.ncbi.nlm.nih.gov/pubmed/25526796
http://dx.doi.org/10.1136/bmjopen-2014-006720
_version_ 1782350162445729792
author Schmidt, Sigrun Alba Johannesdottir
Johansen, Martin Berg
Olsen, Morten
Xu, Xiao
Parker, Joseph M
Molfino, Nestor A
Lash, Timothy L
Sørensen, Henrik Toft
Christiansen, Christian Fynbo
author_facet Schmidt, Sigrun Alba Johannesdottir
Johansen, Martin Berg
Olsen, Morten
Xu, Xiao
Parker, Joseph M
Molfino, Nestor A
Lash, Timothy L
Sørensen, Henrik Toft
Christiansen, Christian Fynbo
author_sort Schmidt, Sigrun Alba Johannesdottir
collection PubMed
description OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period. MAIN OUTCOMES AND MEASURES: Using Cox regression, we computed 0–30-day and 31–365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure. RESULTS: We identified 16 647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort. The 0–30-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31–365. CONCLUSION: Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31–365-day mortality.
format Online
Article
Text
id pubmed-4275660
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42756602014-12-31 The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study Schmidt, Sigrun Alba Johannesdottir Johansen, Martin Berg Olsen, Morten Xu, Xiao Parker, Joseph M Molfino, Nestor A Lash, Timothy L Sørensen, Henrik Toft Christiansen, Christian Fynbo BMJ Open Respiratory Medicine OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period. MAIN OUTCOMES AND MEASURES: Using Cox regression, we computed 0–30-day and 31–365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure. RESULTS: We identified 16 647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort. The 0–30-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31–365. CONCLUSION: Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31–365-day mortality. BMJ Publishing Group 2014-12-19 /pmc/articles/PMC4275660/ /pubmed/25526796 http://dx.doi.org/10.1136/bmjopen-2014-006720 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Respiratory Medicine
Schmidt, Sigrun Alba Johannesdottir
Johansen, Martin Berg
Olsen, Morten
Xu, Xiao
Parker, Joseph M
Molfino, Nestor A
Lash, Timothy L
Sørensen, Henrik Toft
Christiansen, Christian Fynbo
The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title_full The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title_fullStr The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title_full_unstemmed The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title_short The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
title_sort impact of exacerbation frequency on mortality following acute exacerbations of copd: a registry-based cohort study
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275660/
https://www.ncbi.nlm.nih.gov/pubmed/25526796
http://dx.doi.org/10.1136/bmjopen-2014-006720
work_keys_str_mv AT schmidtsigrunalbajohannesdottir theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT johansenmartinberg theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT olsenmorten theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT xuxiao theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT parkerjosephm theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT molfinonestora theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT lashtimothyl theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT sørensenhenriktoft theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT christiansenchristianfynbo theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT schmidtsigrunalbajohannesdottir impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT johansenmartinberg impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT olsenmorten impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT xuxiao impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT parkerjosephm impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT molfinonestora impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT lashtimothyl impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT sørensenhenriktoft impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy
AT christiansenchristianfynbo impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy